e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD
Huiart L., Ernst P., Ranouil X., Suissa S.
Source:
Eur Respir J 2005; 25: 634-639
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Huiart L., Ernst P., Ranouil X., Suissa S.. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J 2005; 25: 634-639
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD
Source: Eur Respir J 2010; 35: 1003-1021
Year: 2010
Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD
Source: Eur Respir J 2007; 29: 1115-1119
Year: 2007
Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD
Source: Eur Respir J 2012; 39: 1097-1103
Year: 2012
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients
Source: Eur Respir J 2004; 23: 692-697
Year: 2004
Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): Effects of exacerbation frequency
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 795-798
Year: 2003
Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction
Source: International Congress 2014 – Comorbidities
Year: 2014
Statin use is associated with reduced mortality in COPD
Source: Eur Respir J 2007; 29: 279-283
Year: 2007
Effect of severity of exacerbations of COPD and hospitalised pneumonia on risk of myocardial infarction
Source: International Congress 2017 – COPD: risk factors and prognosis
Year: 2017
Prolonging the interval to the next acute exacerbations
Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know?
Year: 2005
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
Source: Eur Respir J 2003; 21: 260-266
Year: 2003
Inhaled corticosteroids and hospitalisation due to exacerbation of COPD
Source: Eur Respir J 2003; 22: 286-289
Year: 2003
Severity assessment in acute exacerbations of COPD
Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know?
Year: 2005
Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
Source: Eur Respir J 2010; 36: 751-757
Year: 2010
Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006
The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept